Shares of Ardent Health Partners (ARDT) surged 6.00% in after-hours trading on Tuesday following the release of the company's impressive first-quarter 2025 financial results. The healthcare provider reported earnings per share of $0.29, significantly beating the analyst consensus estimate of $0.20 by 45%.

Ardent Health's total revenue for Q1 2025 reached $1.50 billion, marking a 4.0% increase compared to the same period last year. The company's net income attributable to Ardent Health soared by 52% to $41 million, up from $27 million in Q1 2024. Adjusted EBITDA also saw a 2.5% year-over-year increase, reaching $98 million.

Adding to investor optimism, Ardent Health reaffirmed its full-year 2025 financial guidance, projecting total revenue between $6.2 billion and $6.45 billion and adjusted EBITDA in the range of $575 million to $615 million. The company's strong performance was driven by a 7.6% growth in admissions and successful cost management initiatives, including a reduction in supply costs and moderation of professional fee expenses growth.